The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)
瑞典一项全国性研究(COVID-19-REUMA)评估了接受不同生物制剂或靶向DMARD治疗的炎症性风湿病患者接种第三剂和第四剂COVID-19疫苗的血清免疫原性。
期刊:Microbiology Spectrum
影响因子:3.8
doi:10.1128/spectrum.02981-23
Frodlund, Martina; Nived, Per; Chatzidionysiou, Katerina; Södergren, Anna; Klingberg, Eva; Hansson, Monica; Ohlsson, Sophie; Pin, Elisa; Bengtsson, Anders; Klareskog, Lars; Kapetanovic, Meliha